Since in the present study hOCIF did not decrease TGFβ levels in the TB-interface, treatment with hOCIF may not affect the invasiveness of the tumor cells; however, further studies are necessary to identify the factors other than TGFβ that may be involved in promoting the malignant potential of tumors. This evidence concerns the gene TGFB1 and neoplasm.